Feature|Videos|September 6, 2000

Projecting Pharma's Outlook with Deloitte's Laks Pernenkil

Author(s)Grant Playter

Laks Pernenkil, a partner for Deloitte’s life sciences consulting business, discusses various findings from Deloitte’s research into the biopharma industry.

Laks Pernenkil, a partner for Deloitte’s life sciences consulting business, discusses various findings from Deloitte’s research into the biopharma industry with Grant Playter, associate editor. Topics of discussion include Deloitte’s recent report on the state of biopharma, broader digitalization trends, how generative AI will affect pharma going forward, the push toward supply chain resilience, and more.

About the speaker

[insert text]

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!